John P. Butler - Mar 3, 2025 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Signature
/s/ Carolyn Rucci, attorney-in-fact for John P. Butler
Stock symbol
AKBA
Transactions as of
Mar 3, 2025
Transactions value $
-$84,928
Form type
4
Date filed
3/4/2025, 05:05 PM
Previous filing
Feb 4, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale -$84.9K -46.4K -1.78% $1.83 2.56M Mar 3, 2025 Direct F1, F2
holding AKBA Common Stock 100K Mar 3, 2025 Held By John Butler GRAT November 2019
holding AKBA Common Stock 59.9K Mar 3, 2025 Held by John Butler 2019 GRAT
holding AKBA Common Stock 100K Mar 3, 2025 Held By Dorothy Butler GRAT November 2019
holding AKBA Common Stock 59.9K Mar 3, 2025 Held by Dorothy Butler 2019 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
F2 This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2023.